Published 1 day ago • loading... • Updated 1 day ago

SMART Trial two-year data continues to demonstrate superior valve performance for Evolut TAVR™ system in small annulus patients

Summary by Charleston Gazette-Mail

CRT 2025 Late Breaking Science features largest head-to-head randomized control TAVR trial to primarily enroll women using the two most widely used global TAVR devices

34 Articles

All

Left

Center

Right

The Conway Daily Sun

+32 Reposted by 32 other sources

SMART Trial two-year data continues to demonstrate superior valve performance for Evolut TAVR™ system in small annulus patients

CRT 2025 Late Breaking Science features largest head-to-head randomized control TAVR trial to primarily enroll women using the two most widely used global TAVR devices

1 day ago

Read Full Article

stocktitan.net

Can Evolut TAVR's Superior Performance Transform Heart Valve Treatment? New Data Reveals 9x Advantage

Landmark SMART trial reveals Evolut TAVR's superior valve performance with 5x less thrombosis in small annulus patients, primarily benefiting women across 80+ global sites.

1 day ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year